Literature DB >> 17188064

Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.

Mojca Globocnik Petrovic1, Peter Korosec, Mitja Kosnik, Marko Hawlina.   

Abstract

PURPOSE: To determine the levels of interleukin 8 (IL-8) in the vitreous of patients with proliferative diabetic retinopathy (PDR).
DESIGN: Observational case-control study.
METHODS: Vitreous fluid samples were obtained by vitreoretinal surgery from 71 eyes of patients with diabetes mellitus type 2 with PDR and from 17 eyes of nondiabetic patients with a macular hole. PDR was classified as active and inactive and subdivided according to the extent of large-vessel gliotic obliteration. The cytokine levels were measured by cytometric bead array method.
RESULTS: The vitreous levels of IL-8 were significantly higher in patients with PDR in comparison with the control subjects (P < .001) and in patients with higher extent of large vessel gliotic obliteration (P < .001). A vitreous level of IL-8 was not associated with the presence of active PDR.
CONCLUSION: Increased levels of IL-8 in PDR were associated with a higher extent of large-vessel gliotic obliteration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188064     DOI: 10.1016/j.ajo.2006.07.032

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

1.  Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy.

Authors:  Shuang Li; Xun-An Fu; Xiao-Fang Zhou; You-Yan Chen; Wei-Qun Chen
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

2.  Evaluation of vitreous levels of advanced glycation end products and angiogenic factors as biomarkers for severity of diabetic retinopathy.

Authors:  Makiko Katagiri; Jun Shoji; Noriko Inada; Satoshi Kato; Shigehiko Kitano; Yasuko Uchigata
Journal:  Int Ophthalmol       Date:  2017-03-15       Impact factor: 2.031

3.  Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy.

Authors:  Chuan Sun; Hongsong Zhang; Jingjing Jiang; Yuxin Li; Chuang Nie; Jianwen Gu; Ling Luo; Zhijun Wang
Journal:  Int Ophthalmol       Date:  2019-12-04       Impact factor: 2.031

Review 4.  Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.

Authors:  Ryan H Mason; Samuel A Minaker; Gabriela Lahaie Luna; Priya Bapat; Armin Farahvash; Anubhav Garg; Nishaant Bhambra; Rajeev H Muni
Journal:  Eye (Lond)       Date:  2022-06-07       Impact factor: 4.456

5.  The peroxisome proliferator-activated receptor-β/δ antagonist GSK0660 mitigates retinal cell inflammation and leukostasis.

Authors:  Megan E Capozzi; Sara R Savage; Gary W McCollum; Sandra S Hammer; Carla J Ramos; Rong Yang; Colin A Bretz; John S Penn
Journal:  Exp Eye Res       Date:  2019-11-20       Impact factor: 3.467

Review 6.  The Vitreous Ecosystem in Diabetic Retinopathy: Insight into the Patho-Mechanisms of Disease.

Authors:  Siva S R Iyer; Mollie K Lagrew; Stephanie M Tillit; Ramak Roohipourmoallai; Samuel Korntner
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

7.  Role of inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Ahmed M Abu El-Asrar
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

8.  Aqueous cytokine and growth factor levels do not reliably reflect those levels found in the vitreous.

Authors:  Stephanie M Ecker; Joshua C Hines; Scott M Pfahler; Bert M Glaser
Journal:  Mol Vis       Date:  2011-11-09       Impact factor: 2.367

9.  Proliferative diabetic retinopathy: predictive and preventive measures at hypoxia induced retinal changes.

Authors:  Tatjana Josifova; Ivna Plestina-Borjan; Paul Bernhard Henrich
Journal:  EPMA J       Date:  2010-04-01       Impact factor: 6.543

10.  Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.

Authors:  Mojca Globocnik Petrovic; Peter Korosec; Mitja Kosnik; Josko Osredkar; Marko Hawlina; Borut Peterlin; Daniel Petrovic
Journal:  Mol Vis       Date:  2008-07-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.